SS
ACET icon

SBI Securities’s Adicet Bio ACET Stock Holding History

SBI Securities’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129 Hold
19
– – ﹤0.01% 3348
2025
Q4 		$160 Sell
19
-33
-63% -$365 ﹤0.01% 3281
2025
Q3 		$670 Buy
52
+1
+2% +$12 ﹤0.01% 2857
2025
Q2 		$501 Buy
51
+3
+6% +$32 ﹤0.01% 2965
2025
Q1 		$577 Buy
48
+37
+336% +$529 ﹤0.01% 2812
2024
Q4 		$165 Buy
+11
New +$208 ﹤0.01% 3305

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SBI Securities's ACET Position: Q1 2026 in Review

SBI Securities held its Adicet Bio (ACET) position steady in Q1 2026 at 19 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #3348.

SBI Securities first reported a position in ACET in Q4 2024 and has held it in 6 quarters since. The position peaked at $670 in Q3 2025. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • SBI Securities held 19 shares of Adicet Bio worth $129 as of Q1 2026.
  • SBI Securities left its Adicet Bio share count unchanged in Q1 2026.
  • Adicet Bio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3348 holding.
  • SBI Securities first reported a position in Adicet Bio in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Adicet Bio position peaked at $670 in Q3 2025.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.